SALVO: Single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kottschade, Lisa A
  • Pond, Gregory
  • Olszanski, Anthony J
  • Zakharia, Yousef
  • Domingo-Musibay, Evidio
  • Hauke, Ralph J
  • Curti, Brendan D
  • Schober, Sarah
  • Milhem, Mohammed M
  • Block, Matthew Stephen
  • McWilliams, Robert R

publication date

  • June 1, 2022